- Home
- MNOV vs MHF Comparison
MNOV vs MHF Comparison
Compare MNOV & MHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MNOV | MHF |
|---|---|---|
| Founded | 2000 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 137.8M | 136.5M |
| IPO Year | 2004 | N/A |
Fundamental Metrics
Financial Performance| Metric | MNOV | MHF |
|---|---|---|
| Price | $1.46 | $6.49 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.25 | N/A |
| AVG Volume (30 Days) | 57.5K | ★ 113.6K |
| Earning Date | 11-16-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.29% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,360,807.00 | N/A |
| Revenue This Year | $78.20 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 194.15 | N/A |
| 52 Week Low | $1.22 | $5.84 |
| 52 Week High | $3.90 | $7.22 |
Technical Indicators
Market Signals| Indicator | MNOV | MHF |
|---|---|---|
| Relative Strength Index (RSI) | 42.72 | 48.62 |
| Support Level | $1.28 | $5.84 |
| Resistance Level | $1.54 | $7.04 |
| Average True Range (ATR) | 0.06 | 0.16 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 51.25 | 24.39 |
Price Performance
Historical ComparisonAbout MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.
About MHF Western Asset Municipal High Income Fund Inc.
Western Asset Municipal High Income Fund Inc is a diversified closed-end management investment company. The company's objective is to seek high current income exempt from federal income taxes. It invests predominantly in intermediate and long-term municipal debt securities issued by state and local governments.